INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,730,662 | -22.2% | 52,422 | -5.4% | 0.01% | -16.7% |
Q2 2023 | $3,509,891 | +16.9% | 55,431 | 0.0% | 0.01% | +9.1% |
Q1 2023 | $3,001,589 | +2.3% | 55,431 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $2,933,409 | +18.9% | 55,431 | +4.6% | 0.01% | +10.0% |
Q3 2022 | $2,467,000 | -18.5% | 53,010 | 0.0% | 0.01% | -9.1% |
Q2 2022 | $3,026,000 | -6.7% | 53,010 | 0.0% | 0.01% | +10.0% |
Q1 2022 | $3,244,000 | -11.1% | 53,010 | -24.0% | 0.01% | -9.1% |
Q4 2021 | $3,650,000 | +6.8% | 69,728 | -23.9% | 0.01% | 0.0% |
Q3 2021 | $3,418,000 | +25.8% | 91,672 | +37.7% | 0.01% | +22.2% |
Q2 2021 | $2,718,000 | +25.7% | 66,586 | +4.5% | 0.01% | +12.5% |
Q1 2021 | $2,163,000 | -17.2% | 63,743 | -22.4% | 0.01% | -11.1% |
Q4 2020 | $2,612,000 | +21.4% | 82,133 | -2.0% | 0.01% | 0.0% |
Q2 2020 | $2,152,000 | +177.3% | 83,840 | +34.1% | 0.01% | +200.0% |
Q2 2017 | $776,000 | -23.6% | 62,500 | 0.0% | 0.00% | -25.0% |
Q1 2017 | $1,016,000 | +7.7% | 62,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $943,000 | -1.0% | 62,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $953,000 | -60.7% | 62,500 | 0.0% | 0.00% | -63.6% |
Q2 2016 | $2,426,000 | +39.6% | 62,500 | 0.0% | 0.01% | +37.5% |
Q1 2016 | $1,738,000 | -74.2% | 62,500 | -50.0% | 0.01% | -42.9% |
Q4 2015 | $6,724,000 | +168.6% | 125,000 | +100.0% | 0.01% | +27.3% |
Q3 2015 | $2,503,000 | +74.1% | 62,500 | +38.9% | 0.01% | +83.3% |
Q2 2015 | $1,438,000 | +33.8% | 45,000 | 0.0% | 0.01% | +50.0% |
Q1 2015 | $1,075,000 | +35.4% | 45,000 | 0.0% | 0.00% | +33.3% |
Q4 2014 | $794,000 | +28.7% | 45,000 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $617,000 | -18.7% | 45,000 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $759,000 | – | 45,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |